LUMO
Lumos Pharma, Inc. Common Stock
LUMO
LUMO
Delisted
LUMO was delisted on the 11th of December, 2024.
64 hedge funds and large institutions have $30.5M invested in Lumos Pharma, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 25 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less call options, than puts
Call options by funds: $ | Put options by funds: $
80% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 25
Holders
64
Holding in Top 10
–
Calls
$579K
Puts
$1.42M
Top Buyers
| 1 | +$7.88M | |
| 2 | +$199K | |
| 3 | +$164K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$133K |
| 5 |
Morgan Stanley
New York
|
+$98.7K |
Top Sellers
| 1 | -$980K | |
| 2 | -$658K | |
| 3 | -$434K | |
| 4 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$419K |
| 5 |
Millennium Management
New York
|
-$248K |